| Document |
Document Title |
|
WO/2006/111783A1 |
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and auto...
|
|
WO/2006/112316A1 |
A method for the purification of cellobiose comprising the steps of: (A) preparing a cellobiose-containing sugar solution; (B) adjusting the content of cellobiose in the cellobiose-containing sugar solution to 50% by mass or more relativ...
|
|
WO/2006/104137A1 |
The invention provides a sucrase activity inhibitor and a glucoamylase activity inhibitor comprising one or more saccharides selected from the group consisting of palatinose, trehalose and reduced palatinose. Further, the invention provi...
|
|
WO/2006/100253A2 |
The invention relates to an enzymatic method for synthesizing oligosaccharides, whereby one saccharide group of a sucrose analogue each is transferred onto an acceptor molecule, for example for glycosylating a hydroxyl compound, a saccha...
|
|
WO/2006/101118A1 |
It is intended to provide a novel application of D-psicose (application to suppression of abnormal circadian increase in blood glucose level). It is a composition for suppressing abnormal circadian increase in plasma glucose level contai...
|
|
WO/2006/096963A1 |
The present invention relates to ionic liquids for use in chemical applications and capable of serving the dual function of solvent and liquid support. The ionic liquid lends itself to a method of synthesizing oligomers selected from the...
|
|
WO/2006/093364A1 |
Disclosed a method of producing sugar alcohols through the hydrogenation of sugars using a catalyst in which ruthenium is supported on a zirconia. The method includes hydrogenating sugar under relatively moderate reaction conditions usin...
|
|
WO/2006/086270A1 |
A process for forming lactose suitable for use in a pharmaceutical formulation comprises providing a plurality of lactose particles containing no more than 10% w/w of lactose particles having a volume average particle size of about 70 mi...
|
|
WO/2006/080430A1 |
An ophthalmic medicine composition, in particular, eye-drops, eye ointment, eyewash agent, intraocular perfusate, anterior chamber washing agent, internal medicine, injectable solution or extracted cornea preserving agent that excels in ...
|
|
WO/2006/070862A1 |
A process by which 5-deoxy-L-arabinose, which is important as a material for the production of saproterin, a useful therapeutic agent for atypical hyperphenylalaninemia, can be industrially and efficiently produced even with a simple pro...
|
|
WO/2006/070483A1 |
This invention provides a process for producing a DFA III crystal, characterized in that a solution containing difructose dianhydride III: DFA III, that is, a hardly digestive disaccharide comprising two fructose molecules bonded to each...
|
|
WO/2006/064078A1 |
The invention relates to a method of producing industrially-viable prebiotic oligosaccharides using a novel enzyme of Xanthophyllomyces dendrorhous, which is characterised by having $g(a)-glucosidase activity. The invention also relates ...
|
|
WO/2006/061396A1 |
The invention relates to a compound of general formula (I): where = 0 or 1, Z = O, S or CH2, R1 and R2 independently = OH or OY, where Y = a protecting group, OR3, where R3 = a monosaccharide or disaccharide group, A1-CH2-N+(CH3)3, X-, w...
|
|
WO2005092907B1 |
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and auto...
|
|
WO/2006/054429A1 |
An oral composition for potentiating the production of equol by an intestinal bacterium which contains, as the active ingredient, difructose anhydride for activating the equol productivity of the intestinal bacterium.
|
|
WO/2006/046738A1 |
A process for inexpensively producing an indigestible dextrin which contains an isomerized sugar and is highly useful in foods and beverages. This process comprises the following step (A) and at least one subsequent step selected between...
|
|
WO/2006/038613A1 |
It is considered that the excessive intake of sodium chloride is one of factors causative of the onset and worsening of diseases classified into life-style-related diseases and complications thereof. Thus, it is intended to provide a nov...
|
|
WO/2006/035725A1 |
A novel nonreducing sugar comprising glucose as a constituent sugar; a novel enzyme capable of expanding the room for choice of nonreducing sugar and forming the nonreducing sugar; a forming method and production process therefor; a DNA ...
|
|
WO/2006/026639A1 |
A process for the preparation of an alkoxylated sucrose ester including the steps of: forming an initial reaction mixture of a sucrose ester and from about 0.01% to about 5% of a catalyst; and forming an initial reaction product by react...
|
|
WO/2006/022325A1 |
It is intended to provide a novel and useful galactose derivative constituting a drug carrier by which a drug can be efficiently transported into the liver, a drug carrier containing this derivative and a medicinal composition containing...
|
|
WO/2006/021653A2 |
The invention concerns heparanase inhibiting compounds of general formula (I) wherein R represents a hydrogen atom, an hydroxyl radical, a -OSO3- radical, a -O-(C1-C5)alkyl radical or an -O- aralkyl radical; Z represents a COO- radical o...
|
|
WO/2006/017752A2 |
The invention relates to sulfated oligosaccharides, more particularly to new pharmaceutical uses of sulfated oligosaccharides. The invention provides a method of preventing, treating or alleviating the symptoms of acute and chronic', inf...
|
|
WO/2006/017727A2 |
The invention relates to new polysulfated glycosides of formula (I), the salts thereof formed with alkali metals or alkaline-earth metals, as well as the pharmaceutical compositions containing these compounds as active ingredients. Furth...
|
|
WO/2006/013193A2 |
Described herein are derivatives of arylsulfonamido-substituted hydroxamic acid of formula (I) having good solubility in water and inhibitory activity of matrix metalloproteinases, useful for the preparation of pharmaceutical composition...
|
|
WO/2006/012490A2 |
A novel ketogenic compound is provided having general formula (R(OCH(CH3)CH2C(O))nO)m-A wherein n is a integer between I and 10, m is an integer of 1 to 200,000, A is a monsaccharide, polysaccharide or oligosaccharide residue and R is se...
|
|
WO/2006/011713A1 |
1-&agr -halo-2,2-difluoro-2-deoxy-D-ribofuranose derivative of formula (I) having the 3-hydroxy group protected with a biphenylcarbonyl group is a solid which can be easily purified by a simple procedure such as recrystallization, and th...
|
|
WO/2006/011479A1 |
A process for producing a cellooligosaccharide which comprises enzymatically decomposing in the presence of a cellulase a water-insoluble natural cellulosic substance which has an average degree of polymerization of 700 or lower and an a...
|
|
WO/2006/009353A1 |
3R-carboxylate enantiomer derivative of formula (III) can be prepared easily and selectively by the method of the present invention, and a highly pure D-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative can be prepared efficiently from...
|
|
WO/2006/008379A1 |
The invention relates to a gene encoding a polypeptide exhibiting an endofucanase activity, i.e. an enzyme which degrades fucanes or fucoidans embodied in the form of polysaccharides formed by sulphated fucose units. A method for produci...
|
|
WO/2006/006267A1 |
An antistress agent which contains as an active ingredient a saccharide containing 3-O-&agr -D-glcopyranosyl-D-glucose as a structural unit. When used as a medicine, the antistress agent is free from side effects and can be taken habitua...
|
|
WO/2005/118609A2 |
Provided herein are small molecule stimulators of neuronal growth, their preparation, and their use for treatment of neurological disorders. In one embodiment, provided herein are methods of treatment, prevention, or amelioration of a va...
|
|
WO/2005/118607A1 |
Methods of making hyaluronates, including high molecular weight hyaluronates, are disclosed. The methods include contacting a hyaluronate-containing source with an acid to make an acidic hyaluronate suspension, contacting that suspension...
|
|
WO/2005/115408A1 |
[PROBLEMS] To find out a specific rare sugar having effects of inhibiting the proliferation of vascular endothelial cells and lumen formation and utilize these effects. To provide this rare sugar as a preventive/remedy for diseases with ...
|
|
WO/2005/115409A1 |
[PROBLEMS] To provide a composition for inhibiting the onset of arteriosclerosis by using a rare sugar D-psicose and an inhibition method. [MEANS FOR SOLVING PROBLEMS] A composition for inhibiting the onset of arteriosclerosis characteri...
|
|
WO/2005/113568A1 |
The present invention relates to novel galactosides and the use of the galactosides as a medicament, as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galactin to receptors in a mammal. ...
|
|
WO/2005/107798A1 |
The present invention relates to Neisserial Lipo-Oligo-Saccharides (LOS) that comprise a tri-saccharide outer core that shows increased binding to the DC-SIGN receptor on dendritic cells, as a result of which the Neisserial LOS’s of th...
|
|
WO/2005/103276A1 |
A process comprising causing β-fructofuranosidase derived from a microbe belonging to the genus Bacillus and sucrose unassimilating yeast to act on an aqueous solution containing sucrose and lactose to thereby produce a sugar with a hig...
|
|
WO/2005/100373A2 |
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disclosed herein can be useful for inhibition and prevention of inflammation and associated pathologies, including inflammatory and au...
|
|
WO/2005/097286A1 |
Chromatographic separation equipment characterized in that two pumps are employed for controlling chromatographic separation that combines a first process for supplying at least one of stock solution and eluent into a circulation system ...
|
|
WO/2005/094611A1 |
The present invention provides fat replacement compositions imparting advantageous organoleptic properties to reduced calorie foodstuffs. The fat replacement compositions generally include a mixture of tagatose and at least one indigesti...
|
|
WO/2005/092931A1 |
A sugar donor having a glucuronic acid or iduronic acid derivative at the reducing end and in which a leaving group is added to the reducing end hydroxyl group to be glycosylated and the other hydroxyl groups and the carboxyl groups are ...
|
|
WO/2005/089776A1 |
The present invention provides algin oligosaccharides having polymerized degree of 2-22 and the derivatives thereof, such algin oligosaccharides are made of mannuronic acid bonded by ∝-1,4 glycosidic bond. The derivatives which the red...
|
|
WO/2005/090411A1 |
The invention provides a process for preparing heparin products with a reduced content of glycoserine. A method for detecting glycoserine in preparations of heparin is also provided.
|
|
WO/2005/090376A1 |
Disclosed herein is a process for producing chlorinated sucrose, mainly 1',6'-Dichloro-1',6'-Dideoxy-β-D-Fructo-Furanosyl-4-Chloro-
4-Deoxy-&agr -D-Galactopyranoside by chlorination of 6-acetyl sucrose in the presence of a solvent such ...
|
|
WO/2005/090375A1 |
The invention relates to a method for enriching trehalose from solutions, wherein the enrichment is performed with the aid of an adsorbent. The invention is characterized in that the adsorbent is an alumosilicate. The alumosilicate is pr...
|
|
WO/2005/086612A2 |
Disclosed are novel conjugates that include fluorinated carbohydrate molecules and methods for synthesizing the conjugates. The fluorinated carbohydrate molecule may include a radioisotope. The method of synthesizing the conjugate is use...
|
|
WO/2005/085263A1 |
The invention relates to a molecular spacer, to a method of fixing a molecular unit to a solid support and to the use of said spacer on analysis chips with molecules or biomolecules. According to the invention, the spacer has formula (I)...
|
|
WO/2005/085264A1 |
The invention relates to compounds which are polysufated oligosaccharide derivatives having activity as inhibitors of heparan sulfate-binding proteins and inhibitors of the enzyme heparanase; methods for the preparation of the compounds;...
|
|
WO/2005/080489A1 |
The present invention discloses a solution of metal-polymer chelate(s) and applications thereof. The solution is prepared as follows: the carbohydrate ,and/or the polymer having hydroxyl, and/or the polymer having hydroxyl , amino and/or...
|
|
WO/2005/078140A1 |
A process for producing a monosaccharide from biomass, comprising the first step (3) of conducting pretreatment of biomass as a raw material in 65 to 85 mass% sulfuric acid at 30 to 70°C and the second step (4) of saccharifying the prod...
|
